ET
Embold Therapeutics, Inc.
SEC filingBiotechnology · Redwood City, CA
Amount raised$2.5Msold at filing
Total offering$5M$2.5M still open
Investors in the raise7count reported to the SEC
FiledJul 24, 2026first sale Jan 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gjalt W. HuismanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.